New Warnings Added to Labeling of Hepatitis C Treatments

• Autores: Diane S. Aschenbrenner
• Localización: American Journal of Nursing, ISSN 0002-936X, Vol. 116, Nº. 2, 2016, págs. 22-22
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • * The combination antiviral therapies Viekira Pak and Technivie, used to treat moderate or severe hepatitis C, can lead to serious liver injury.

    * Nurses should monitor liver values and instruct patients to look for symptoms of liver disease, including fatigue, weakness, a lack of appetite, nausea and vomiting, and jaundice.